Uncertainty quantification for a model of HIV-1 patient response to antiretroviral therapy interruptions
暂无分享,去创建一个
H. T. Banks | Kevin B. Flores | Robert Baraldi | Laura Poag | Karissa Cross | Christina McChesney | Emma Thorpe | H. Banks | C. McChesney | K. Flores | R. Baraldi | Emma Thorpe | Karissa Cross | Laura Poag
[1] R. Sherer,et al. Management of the adverse effects of antiretroviral therapy and medication adherence. , 2000, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[2] C. Rouzioux,et al. Proviral HIV-1 DNA in subjects followed since primary HIV-1 infection who suppress plasma viral load after one year of highly active antiretroviral therapy , 2001, AIDS.
[3] H. Banks,et al. Mathematical and Experimental Modeling of Physical and Biological Processes , 2009 .
[4] Matthew C Strain,et al. Effect of treatment, during primary infection, on establishment and clearance of cellular reservoirs of HIV-1. , 2005, The Journal of infectious diseases.
[5] Jonathan AC Sterne,et al. Prognosis of HIV-1-infected patients starting highly active antiretroviral therapy: a collaborative analysis of prospective studies , 2002, The Lancet.
[6] Kapil Bahl,et al. Type 1 Interferons and Antiviral CD8 T-Cell Responses , 2012, PLoS pathogens.
[7] Cyril Dalmasso,et al. Distinct Genetic Loci Control Plasma HIV-RNA and Cellular HIV-DNA Levels in HIV-1 Infection: The ANRS Genome Wide Association 01 Study , 2008, PloS one.
[8] Michael J. Bevan,et al. CD8+ T Cells: Foot Soldiers of the Immune System , 2011, Immunity.
[9] H. T. Banks,et al. Standard error computations for uncertainty quantification in inverse problems: Asymptotic theory vs. bootstrapping , 2010, Math. Comput. Model..
[10] B. Berkhout,et al. Dendritic Cell-induced Activation of Latent HIV-1 Provirus in Actively Proliferating Primary T Lymphocytes , 2013, PLoS pathogens.
[11] Kevin Flores,et al. Uncertainty quantification in modeling HIV viral mechanics. , 2015, Mathematical biosciences and engineering : MBE.
[12] S. Paludan,et al. Innate immune recognition and activation during HIV infection , 2010, Retrovirology.
[13] Christopher Wilhelm,et al. CD4 and CD8 T Cell Immune Activation during Chronic HIV Infection: Roles of Homeostasis, HIV, Type I IFN, and IL-7 , 2011, The Journal of Immunology.
[14] Shuhua Hu,et al. Modelling HIV immune response and validation with clinical data , 2008, Journal of biological dynamics.
[15] C. Rouzioux,et al. Immunovirologic control 24 months after interruption of antiretroviral therapy initiated close to HIV seroconversion. , 2013, JAMA internal medicine.
[16] R. Siliciano,et al. HIV latency. , 2011, Cold Spring Harbor perspectives in medicine.
[17] R. Siliciano,et al. The challenge of viral reservoirs in HIV-1 infection. , 2002, Annual review of medicine.
[18] C. Rouzioux,et al. HIV controllers: a homogeneous group of HIV-1-infected patients with spontaneous control of viral replication. , 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[19] Sadikalmahdi Abdella,et al. Management of common adverse effects in the era of highly active antiretroviral therapy in south east Ethiopia , 2011, North American Journal of Medicine and Science.
[20] R. Siliciano,et al. Stimulation of HIV-1-specific cytolytic T lymphocytes facilitates elimination of latent viral reservoir after virus reactivation. , 2012, Immunity.
[21] G. Carcelain,et al. Immune responses driven by protective human leukocyte antigen alleles from long-term nonprogressors are associated with low HIV reservoir in central memory CD4 T cells. , 2012, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[22] Yujie Liu,et al. Cellular reservoirs of HIV-1 and their role in viral persistence. , 2008, Current HIV research.